iCoreConnect CEO Robert McDermott Receives Leadership Recognition from Healthcare Business Review

OCOEE, FL, Aug. 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire iCoreConnect, Inc. (OTCQB: ICCT) (“iCore” or the “Company”), a leading cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise and healthcare workflow platform, today announced that President and Chief Executive Officer, Robert McDermott, was recently recognized by Healthcare Business Review for his leadership at iCoreConnect.

In the feature article, Healthcare Business Review highlights how Mr. McDermott is successfully leading the Company in its mission to solve significant pain points in dental and medical practices with its cutting-edge products and technology. By staying close to the end-user and attaining first-hand knowledge of the challenges they face, iCoreConnect provides customers with critical solutions which improve profitability and efficiency as well as the patient experience.

McDermott commented, “The industry has been underserved for years regarding cloud-based products. We have brought cost-effective solutions to the market that do not require a significant upfront investment. Importantly, our solutions can function on a standalone basis or can be seamlessly integrated with most practice management software."

McDermott concluded, "Strategic partnerships with Practice Management System (PMS) and Electronic Health Record (EHR) vendors enable most of iCoreConnect’s products to integrate directly with any medical or dental software. Integration dramatically improves efficiency by not requiring the end user to re-enter patient data that already exists in the practice software. Additionally, it eliminates errors and data duplication commonly found in a typical practice which uses 10 different software products, on average. Most importantly, delivering these solutions remotely via the cloud adds portability, convenience and efficiencies not found in other on-premises software, creating a significant competitive advantage.”

Link to the full article: https://www.healthcarebusinessreview.com/icoreconnect

Forward-Looking Statements
Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the Company’s revenue and annualized recurring revenue estimates for 2023, the Company’s ability to grow opportunities within ePrescription and insurance verification, and the Company's ability to continue to expand its reach into medical customers. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. The Company has attempted to identify forward-looking statements by terminology including ‘believes,’ ‘estimates,’ ‘anticipates,’ ‘expects,’ ‘plans,’ ‘projects,’ ‘intends,’ ‘potential,’ ‘may,’ ‘could,’ ‘might,’ ‘will,’ ‘should,’ ‘approximately’ or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. “Risk Factors” in the Company’s most recently filed Form 10-K filed with the Securities and Exchange Commission (“SEC”) and updated from time to time in its Form 10-Q filings and in its other public filings with the SEC. Any forward-looking statements contained in this release speak only as of its date. The Company undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.

About iCoreConnect
iCoreConnect, Inc. is a market-leading cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise and healthcare workflow platform of applications and services. iCoreConnect is most notably known for its innovation in solving healthcare business problems. iCoreConnect’s philosophy places a high value on customer feedback, allowing iCoreConnect to respond to the market’s needs. iCoreConnect touts a platform of 16 SaaS enterprise solutions and more than 100 agreements with state or regional healthcare associations across the United States.

Investor Contact
888.810.7706, Option 6

Primary Logo

Source: iCoreConnect Inc.